Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03745118 · ClinicalTrials.gov registry record · NA
Development of a Practical, Minimally Invasive Seizure Gauge
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03745118: Completed NA study, sponsored by Mayo Clinic.
NCT03745118 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03745118, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The researchers are trying to assess changes in physiological signals before and during seizures.
Interventions
- DEVICE EpiTel EpiLog
- DEVICE Byte Flies Sensor Dots
- DEVICE Empatica E4
- DEVICE Biovotion Everion
- DEVICE GeneActiv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2022-08-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03745118
The ClinicalTrials.gov registry entry for NCT03745118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which EpiTel EpiLog is the first listed.
NCT03745118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03745118 about?
NCT03745118 is a clinical study titled "Development of a Practical, Minimally Invasive Seizure Gauge". The researchers are trying to assess changes in physiological signals before and during seizures.
What is the current status of trial NCT03745118?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2018-11-19. Estimated completion is 2022-08-05.
What interventions are being tested in trial NCT03745118?
The interventions under investigation include: EpiTel EpiLog (DEVICE), Byte Flies Sensor Dots (DEVICE), Empatica E4 (DEVICE), Biovotion Everion (DEVICE), GeneActiv (DEVICE).
Who is sponsoring clinical trial NCT03745118?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.